Care For The Cancer Caregiver: A Meaning-Based Workshop To Help Manage Caregiver Burden

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02250911

Enrollment

Registered

2014-09-26

Start date

2014-09-30

Completion date

2018-08-31

Last updated

2018-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregivers

Keywords

Caregivers of patients, CCC = Care for the Cancer Caregivers, MCP-C = Meaning-Centered Psychotherapy for Cancer Caregivers, 14-208

Brief summary

The purpose of this study is to gather information on how easy it is to implement the workshop, as well as whether individuals find this workshop helpful. In this study, participants will be assigned at random to one of the two study groups. Based on the information we obtain, we hope to develop an easily accessible support service for caregivers.

Interventions

OTHERwebcasts

BEHAVIORALAssessments

OTHERUsual care

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* As per self report, a current caregiver to a patient with any site or stage of cancer * Age 18 or over * A score of \> 4 on the Distress Thermometer (DT) and indication that this distress is related in some way to the caregiving role * In the judgment of the investigators and/or consenting professional, able to comprehend English to complete study assessments * Able to perform informed consent * Enrollment is open to caregivers with their own current/past cancer histories

Exclusion criteria

* Significant psychiatric or cognitive disturbance sufficient, in the investigator's judgment, to preclude providing informed consent. * As per self report, unable to access a computer with Internet or unable to use a computer with Internet provided by the study * Participated in the development and refinement of the CCC Workshop (prospective exemption X14-006)

Design outcomes

Primary

Measure	Time frame	Description
feasibility of this novel approach	2 years	which will be measured by our ability to recruit our target sample and the proportion of participants who complete the CCC Workshop. Additional indices related to this aim (acceptability) will be gathered via both quantitative (entire sample) and qualitative (with a subset of participants randomized to received the CCC Workshop) methods.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026